This Week at FDA: RFK’s MAHA report, VRBPAC recommends COVID-19 boosters target newer JN.1 strains

This Week at FDA

This Week at FDAFerdous Al-Faruque

Biologics/ biosimilars/ vaccinesGovernment/legislationMedical DevicesPharmaceuticalsPublic healthRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)